Corrigendum to "The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review" [J. Pharma. Anal. 11 (2021) 265-271] - Leonny Dwi Rizkita; Indwiani Astuti (Elsevier, 2022)